TVT
<ѻý class="page-description">Transcatheter Valve Therapyѻý>Approval study analysis suggests best practices
But procedure no less effective for this higher risk group, COAPT trial post hoc analysis shows
Pooled 2-year data show risks, raise concern about impact on ventricles
Benefits similar across anatomical complexity, advanced heart failure in post-marketing studies
First-in-human experience weighs in on device that twists the left atrial appendage closed
Do worst-performing sites need more education about best practices?
Many unanswered questions remain regarding devices for tricuspid regurgitation
Clinical outcomes are headed in the right direction, but better research is needed
Real-world outcomes in people with secondary MR who don't fit COAPT criteria
Observational study suggests excess readmissions with less invasive procedure
Next-generation LAA occluder maintains good results at 2 years
Current GDMT titration approach under fire during TVT debate
Are observational data on highly selected patients good enough?
Differences observed in stroke and pacemaker rates
-
AHA: American Heart Association
November 2024
-
TCT: Transcatheter Cardiovascular Therapeutics
October 2024
-
HFSA: Heart Failure Society of America
September 2024
-
ESC: European Society of Cardiology Congress
August 2024